Liver Institute of Virginia

Richmond, Virginia 23249

0 studies enrolling now · 6 studies all time

What they study most

Chronic Hepatitis C, End Stage Renal Disease, Hepatitis C Virus Infection, Hepatitis C, Chronic, Primary Biliary Cirrhosis, Severe Alcoholic Hepatitis

Studies at this site

• Evaluation of HepQuant SHUNT to Assess Liver Disease; Substudy Within GS-US-416-2124 — Withdrawn before enrolling
• Phase 3 Study of Obeticholic Acid in Patients With Primary Biliary Cirrhosis — Completed
• Safety and Efficacy of Voxilaprevir Plus Sofosbuvir/Velpatasvir Fixed Dose Combination in Adults With Chronic Genotype 1 HCV Infection — Completed
• Safety and Efficacy of Voxilaprevir Plus Sofosbuvir/Velpatasvir Fixed Dose Combination in Adults With Chronic Non-Genotype 1 HCV Infection — Completed
• Oral Antivirals (GS-5885, Tegobuvir, and/or GS-9451) With Peginterferon Alfa 2a and Ribavirin in Treatment Experienced Subjects With Chronic Genotype 1 Hepatitis C Virus Infection — Completed
• A Pilot Study to Treat Patients With Chronic Hepatitis C Virus (HCV) Genotype 1 and End-Stage Renal Disease (ESRD) — Status unconfirmed